These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1857700)

  • 1. [Detection and prevention of the malfunction of an insulin dosing device under clinical conditions].
    Dreval' AV; Postoiuk NI; Galitskiĭ AB; Liashchenko AM
    Probl Endokrinol (Mosk); 1991; 37(2):39-40. PubMed ID: 1857700
    [No Abstract]   [Full Text] [Related]  

  • 2. Implantable continuous intravenous insulin infusion device. Restoration of flow after slow-down.
    Kernstine KH; Kryjeski SR; Wigness BD; Goldenberg FJ; Rohde TD; Dorman FD; Chute EP; Rupp WM; Buchwald H
    ASAIO Trans; 1986; 32(1):511-4. PubMed ID: 3778759
    [No Abstract]   [Full Text] [Related]  

  • 3. Needle detachment from the Sure-T infusion set in two young children with diabetes mellitus (DM) treated with continuous subcutaneous insulin infusion (CSII) and unexplained hyperglycaemia.
    Massa G; Gys I; Eyndt AO; Wauben K; Vanoppen A
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):237-9. PubMed ID: 25153227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Museum visit leading to insulin pump malfunction.
    Tritos NA; Casper K; King G
    Ann Intern Med; 1997 May; 126(9):746. PubMed ID: 9139577
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of long-term subcutaneous infusion of insulin using an attached drug dosing device on indices of hemocoagulation in type I diabetes mellitus].
    Akhmedova ND; Akbarov ZS; Turakulov IaKh
    Probl Endokrinol (Mosk); 1988; 34(5):7-11. PubMed ID: 3217395
    [No Abstract]   [Full Text] [Related]  

  • 6. Significant time until catheter occlusion alerts in currently marketed insulin pumps at two basal rates.
    van Bon AC; Dragt D; DeVries JH
    Diabetes Technol Ther; 2012 May; 14(5):447-8. PubMed ID: 22548715
    [No Abstract]   [Full Text] [Related]  

  • 7. "Toxic shock:" can playground static cause insulin pump failure?
    Baum CR
    Ann Emerg Med; 2007 Jan; 49(1):113. PubMed ID: 17197296
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ketoacidosis during insulin pump therapy--an acceptable risk?].
    Walter H; Mehnert H
    Dtsch Med Wochenschr; 1989 May; 114(18):722-5. PubMed ID: 2496966
    [No Abstract]   [Full Text] [Related]  

  • 9. Rupture of needle during infusion with portable insulin pump in children.
    Wieliczko MC; Mallet E
    Diabetes Care; 1989 Jun; 12(6):440. PubMed ID: 2731465
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical monitoring of miniaturized insulin infusion pumps for increased therapeutical security in the treatment of type-I diabetics.
    Tschöpe D; Schumacher M; Gries A
    Med Prog Technol; 1987; 13(1):47-52. PubMed ID: 3441243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin pumps. Not just for type 1.
    Chait J
    Diabetes Self Manag; 2005; 22(1):37-8, 41. PubMed ID: 15706652
    [No Abstract]   [Full Text] [Related]  

  • 13. [Portable infusion pumps for insulin administration in type I diabetic patients].
    Wilke W; Hüttl I
    Z Arztl Fortbild (Jena); 1989; 83(9):449-53. PubMed ID: 2665333
    [No Abstract]   [Full Text] [Related]  

  • 14. Mortality among diabetic patients using continuous subcutaneous insulin-infusion pumps.
    Teutsch SM; Herman WH; Dwyer DM; Lane JM
    N Engl J Med; 1984 Feb; 310(6):361-8. PubMed ID: 6419110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin therapy with pens and pumps].
    Schwedes U
    Med Klin (Munich); 1996 Feb; 91 Suppl 1():16. PubMed ID: 8839106
    [No Abstract]   [Full Text] [Related]  

  • 16. [The 1989 Apollinaire Bouchardat Award. Treatment of diabetes mellitus with the insulin implantable pump: is it coming soon?].
    Selam JL
    Journ Annu Diabetol Hotel Dieu; 1989; ():273-87. PubMed ID: 2668619
    [No Abstract]   [Full Text] [Related]  

  • 17. Stabilized human insulin prevents catheter occlusion during continuous subcutaneous insulin infusion.
    Walter HM; Timmler R; Mehnert H
    Diabetes Res; 1990 Feb; 13(2):75-7. PubMed ID: 2091873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
    Buysschaert M; Lejeune M; Lambert AE
    Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined use of automatic systems for treating patients with type 1 diabetes mellitus].
    Perelygina AA; Antsiferov MB; Starostina EG
    Probl Endokrinol (Mosk); 1987; 33(5):3-6. PubMed ID: 3422932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucose sensors and insulin infusion systems--current technical status and future aspects].
    Pfeiffer EF
    Verh Dtsch Ges Inn Med; 1989; 95():725-36. PubMed ID: 2690538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.